Mohamed Kandeel El-Ashrey (Mohamed K El-Ashrey)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Structure Activity Relationship

Epidermal Growth Factor Receptor

Endoplasmic Reticulum Stress

Molecular Docking

Top Venues

Future medicinal chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ayman B Farag, Aya H Othman, Mohamed Kandeel El-Ashrey, Safinaz E-S Abbas, Tamer A Elwaie
New 6-nitro-4-substituted quinazoline derivatives targeting epidermal growth factor receptor: design, synthesis and in vitro anticancer studies. Future medicinal chemistry (2024)
Akram H Abd El-Haleem, Manar A Ellafy, Safinaz E-S Abbas, Mohamed Kandeel El-Ashrey
Design, synthesis and anticancer evaluation of some novel 7-hydroxy-4-methyl-3-substituted benzopyran-2-one derivatives. Future medicinal chemistry (2024)
Akram H Abd El-Haleem, Manar A Ellafy, Safinaz E-S Abbas, Mohamed Kandeel El-Ashrey
Design, synthesis and anticancer evaluation of some novel 7-hydroxy-4-methyl-3-substituted benzopyran-2-one derivatives. Future medicinal chemistry 16 (5) (2024)
Akram H Abd El-Haleem, Manar A Ellafy, Safinaz E-S Abbas, Mohamed Kandeel El-Ashrey
Design, synthesis and anticancer evaluation of some novel 7-hydroxy-4-methyl-3-substituted benzopyran-2-one derivatives. Future medicinal chemistry 16 (5) (2024)
Akram H Abd El-Haleem, Manar A Ellafy, Safinaz E-S Abbas, Mohamed Kandeel El-Ashrey
Design, synthesis and anticancer evaluation of some novel 7-hydroxy-4-methyl-3-substituted benzopyran-2-one derivatives. Future medicinal chemistry 16 (5) (2024)
Tarfah Al-Warhi, Hadia Almahli, Raed M Maklad, Zainab M Elsayed, Mahmoud A El Hassab, Ohoud J Alotaibi, Nada Aljaeed, Rezk R Ayyad, Hazem A Ghabour, Wagdy M Eldehna, Mohamed Kandeel El-Ashrey
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights. Molecules (Basel, Switzerland) 28 (7) (2023)
Eman A Mostafa, Mohamed Kandeel El-Ashrey, Sally Tarek Mahmoud
An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets. BMC chemistry 17 (1) (2023)
Abdalla R Mohamed, Ahmed Mostafa, Mahmoud A El Hassab, Gomaa M Hedeab, Sara H Mahmoud, Riham F George, Hanan H Georgey, Nagwa M Abdel Gawad, Mohamed Kandeel El-Ashrey
Insights into targeting SARS-CoV-2: design, synthesis, in silico studies and antiviral evaluation of new dimethylxanthine derivatives. RSC medicinal chemistry 14 (5) (2023)
Eman M Mohi El-Deen, Manal M Anwar, Amina A Abd El-Gwaad, Eman A Karam, Mohamed Kandeel El-Ashrey, Rafika R Kassab
Novel Pyridothienopyrimidine Derivatives: Design, Synthesis and Biological Evaluation as Antimicrobial and Anticancer Agents. Molecules (Basel, Switzerland) 27 (3) (2022)
Nahed Nasser Eid El-Sayed, Norah M Almaneai, Abir Ben Bacha, Mohamed Kandeel El-Ashrey, Maha I Al-Zaben, Zainab M Almarhoon
Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents. ACS omega 7 (22) (2022)
Shimaa Kamal, Hamed Ahmed Derbala, Seham Soliman Alterary, Abir Ben Bacha, Mona Alonazi, Mohamed Kandeel El-Ashrey, Nahed Nasser Eid El-Sayed
Synthesis, Biological, and Molecular Docking Studies on 4,5,6,7-Tetrahydrobenzo[b]thiophene Derivatives and Their Nanoparticles Targeting Colorectal Cancer. ACS omega 6 (43) (2021)